Helicid (4-hydroxy-3-methoxybenzaldehyde-β-D-glucopyranoside)

Helicid (4-hydroxy-3-methoxybenzaldehyde-β-D-glucopyranoside) is a phenolic glycoside that may support cognitive function and mood through hippocampal neurogenesis. Preliminary animal studies suggest it activates the cAMP/PKA/CREB signaling pathway to enhance memory formation and reduce depressive symptoms.

Origin & History

Helicid (4-hydroxy-3-methoxybenzaldehyde-β-D-glucopyranoside) is a phenolic glycoside compound isolated from the seeds of the Chinese herb Helicia nilagirica (family Proteaceae). It is typically obtained in purified form (≥98% purity) for research purposes, though specific extraction methods are not detailed in available sources.

Historical & Cultural Context

Helicid is derived from Helicia nilagirica seeds, a Chinese herb, though specific traditional medicine applications or historical usage patterns are not documented in available sources. Modern research focuses on the isolated compound's bioactive properties rather than traditional ethnopharmacological uses.

Health Benefits

• May improve depressive symptoms in animal models through hippocampal neurogenesis and cAMP/PKA/CREB pathway activation (preliminary evidence from rat studies)
• Potentially enhances cognitive function and spatial memory performance in stress models (based on Morris water maze testing in rats)
• Could promote neuronal proliferation in hippocampal CA1 and dentate gyrus regions (demonstrated in preclinical models only)
• May reduce stress-induced behavioral changes including improved sucrose preference and locomotor activity (shown in chronic unpredictable mild stress rat models)
• Potentially protects against neuronal apoptosis by reducing cleaved caspase-3 levels (preliminary evidence from animal studies)

How It Works

Helicid activates the cyclic adenosine monophosphate (cAMP)/protein kinase A (PKA)/cAMP response element-binding protein (CREB) signaling pathway in hippocampal neurons. This activation promotes brain-derived neurotrophic factor (BDNF) expression and stimulates neurogenesis in the dentate gyrus region. The compound's phenolic structure allows it to cross the blood-brain barrier and modulate neurotransmitter systems involved in memory consolidation and mood regulation.

Scientific Research

Current evidence is limited to preclinical rat studies using chronic unpredictable mild stress (CUMS) models. One study (PMID: 31257291) examined 60 Sprague-Dawley rats over 12 weeks, administering helicid at 8-32 mg/kg orally for 6 weeks, demonstrating improved behavioral and cognitive outcomes. No human clinical trials, RCTs, or meta-analyses have been conducted.

Clinical Summary

Current evidence for helicid is limited to preclinical animal studies, primarily conducted in rat models. Morris water maze testing showed improved spatial memory performance and reduced escape latency times in stressed rats treated with helicid. Depression-related studies demonstrated increased hippocampal cell proliferation and improved behavioral outcomes in forced swim tests. No human clinical trials have been conducted to date, making the therapeutic relevance uncertain.

Nutritional Profile

Helicid (4-hydroxy-3-methoxybenzaldehyde-β-D-glucopyranoside) is a pure isolated phytochemical compound, not a food or nutritional source, and therefore does not possess a conventional nutritional profile with macronutrients, micronutrients, vitamins, minerals, fiber, or protein content. It is a phenolic glycoside with molecular formula C14H18O8 and molecular weight of 314.29 g/mol. Structurally, it consists of a vanillin (4-hydroxy-3-methoxybenzaldehyde) aglycone moiety linked via a β-glycosidic bond to a D-glucopyranose sugar unit. As a bioactive compound, it belongs to the phenylpropanoid-derived aldehyde glycoside class. It is naturally found in the bark of Helicia species (Proteaceae family) at concentrations typically ranging from 0.1–1.5% dry weight depending on plant part and extraction method. Bioavailability data in humans is limited; however, as a glycoside, it is presumed to undergo hydrolysis by intestinal β-glucosidases or colonic microbiota to release the aglycone vanillin, which may influence absorption kinetics. Studies in rodents typically employ doses of 10–80 mg/kg body weight administered orally or intraperitoneally. No caloric value, mineral content, or vitamin content is applicable to this isolated compound.

Preparation & Dosage

No human dosage data exists. Rat studies used oral doses of 8-32 mg/kg/day via gavage for 6 weeks, with 32 mg/kg showing significant effects. Research utilized purified compound (≥98% purity) rather than standardized extracts. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

St. John's Wort, Rhodiola, Lion's Mane, Phosphatidylserine, Bacopa monnieri

Safety & Interactions

Safety data for helicid supplementation in humans is currently unavailable due to lack of clinical trials. As a phenolic glycoside, it may theoretically interact with medications metabolized by cytochrome P450 enzymes, though specific interactions have not been documented. Pregnant and breastfeeding women should avoid helicid supplements due to insufficient safety data. Individuals taking antidepressant medications should consult healthcare providers before use due to potential additive effects on neurotransmitter pathways.